Osr Holdings Inc (OSRH)

$0.42 -0.02 (-3.94%)
Market Cap 10.65M
Revenue (ttm) 0.00
Net Income (ttm) -2.41M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.03
Volume 263,600
Avg Vol 1,583,162
Day's Range N/A - N/A
Shares Out 25.67M
Stochastic %K 3%
Beta 1.41
Analysts Strong Buy
Price Target N/A

Company Profile

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is...

Industry: Biotechnology
Sector: Healthcare
Phone: 425 635 7700
Address:
10900 NE 4th Street, Suite 2300, Bellevue, United States
Bearbull_Baggins
Bearbull_Baggins Feb. 23 at 2:18 PM
$OSRH GATHER ROUND EVERYONE. I have a little story for you about an emerging international healthcare holding company currently cpiling up for a violent price discovery. Story continues in comment section...
3 · Reply
KeepItRealistic
KeepItRealistic Feb. 23 at 2:01 PM
$OSRH company often likes putting out news between 9:30am - 10:00am 👀’s on possible 6 month extension news which can come any day now
0 · Reply
Carter123456
Carter123456 Feb. 23 at 1:04 PM
$OSRH news this week?
1 · Reply
KeepItRealistic
KeepItRealistic Feb. 22 at 6:57 PM
$OSRH When combined with RMC's established, cash-flow-generating operating platform, we believe Woori IO's differentiated technology and expanded commercial optionality create a compelling foundation for growth. Upon consummation of such merger, the combined entity will be evaluated with a view toward a Korean listing, with consideration given to the growth-oriented KOSDAQ market which has recently reached its highest index level in approximately 25 years.
0 · Reply
JeffersonSovereign
JeffersonSovereign Feb. 22 at 6:20 PM
$OSRH 500$ Osrh 5x = 2500$ Gcts 10x = 25 000$ Something else 3-5x = 100 000$ That easy with luck heh
1 · Reply
Bearbull_Baggins
Bearbull_Baggins Feb. 22 at 12:43 AM
$OSRH So this is super interesting. I found this on Fintel. Someone back in November laid out a crazy detailed analysis of OSRHs price action and the obvious manipulation we see from low volume slow drawn out downward pressure to random lightning quick spikes, and requested it be analyzed by Fintel AI. Here is the answer. This is all still very relevant and should make you feel confident a major re-pricing is literally inevitable.
1 · Reply
Bearbull_Baggins
Bearbull_Baggins Feb. 21 at 11:22 PM
$OSRH New 13Fs were updated last week. While it is difficult for a stock like this to even be eligible for most institutions to invest in yet, we are indeed getting buys. And these guys obviously aren't worried about price: Advisor Group Holdings (NEW) Point72 Asset Management (NEW) Jane Street Group (NEW) Mint Tower Capital Management (HELD) Vanguard Group (HELD) Geode Capital Management (INCREASE +3.09%) UBS Group AG (RE-INVESTED) Once this is officially "de-risked", this stock is going to violently surge due to both retail day traders and new institutional interest competing for shares in this tiny float.
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 21 at 4:41 PM
$OSRH the six month bid compliance extension news will likely be announced this coming week Many will be chasing after this news removes all fears and sets up for the other major catalysts listed below which will then move us towards our $10 🎯 👇 - Woori IO distribution news - $815M Term sheet update on Vaximm - RMC & Woori IO merger + IPO https://www.newsfilecorp.com/release/276983/Emerging-Growth-Research-Issues-Flash-Report-on-OSR-Holdings-Inc.-Reaffirms-BuyEmerging-Rating-and-10.00-Price-Target-Following-Major-Licensing-Agreement
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 21 at 12:09 AM
$OSRH ZERO effect painting a close 👇
0 · Reply
Hritzko
Hritzko Feb. 20 at 11:07 PM
$OSRH Added another 5k near close . OSRH News imminent imho on any front including business operations.
0 · Reply
Latest News on OSRH
CEO Statement to Shareholders

Feb 2, 2026, 9:50 AM EST - 20 days ago

CEO Statement to Shareholders

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

Jan 27, 2026, 8:30 AM EST - 27 days ago

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Jan 22, 2026, 9:55 AM EST - 4 weeks ago

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Jan 16, 2026, 9:20 AM EST - 5 weeks ago

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Jan 12, 2026, 8:05 AM EST - 6 weeks ago

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Dec 19, 2025, 11:50 AM EST - 2 months ago

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Dec 4, 2025, 3:19 PM EST - 2 months ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Dec 2, 2025, 9:53 AM EST - 2 months ago

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

Dec 1, 2025, 3:01 PM EST - 2 months ago

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

Nov 21, 2025, 9:20 AM EST - 3 months ago

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

Nov 14, 2025, 11:10 AM EST - 3 months ago

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Nov 6, 2025, 8:30 AM EST - 3 months ago

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

Oct 20, 2025, 11:39 AM EDT - 4 months ago

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

Oct 14, 2025, 8:30 AM EDT - 4 months ago

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

Sep 9, 2025, 5:30 PM EDT - 5 months ago

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Aug 1, 2025, 1:29 PM EDT - 7 months ago

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

OSR Holdings Provides Transparency Update on Equity Financing Instruments

Jul 31, 2025, 12:45 PM EDT - 7 months ago

OSR Holdings Provides Transparency Update on Equity Financing Instruments

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

Jul 30, 2025, 4:10 PM EDT - 7 months ago

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

Jul 24, 2025, 7:30 AM EDT - 7 months ago

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

Jul 15, 2025, 7:30 AM EDT - 7 months ago

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

Jul 9, 2025, 7:58 AM EDT - 8 months ago

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

May 22, 2025, 7:36 AM EDT - 9 months ago

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

May 2, 2025, 7:30 AM EDT - 10 months ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

Apr 9, 2025, 7:54 AM EDT - 11 months ago

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Apr 3, 2025, 7:30 AM EDT - 11 months ago

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Mar 26, 2025, 7:16 AM EDT - 11 months ago

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Mar 25, 2025, 7:00 AM EDT - 11 months ago

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

Feb 14, 2025, 6:10 PM EST - 1 year ago

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

Bearbull_Baggins
Bearbull_Baggins Feb. 23 at 2:18 PM
$OSRH GATHER ROUND EVERYONE. I have a little story for you about an emerging international healthcare holding company currently cpiling up for a violent price discovery. Story continues in comment section...
3 · Reply
KeepItRealistic
KeepItRealistic Feb. 23 at 2:01 PM
$OSRH company often likes putting out news between 9:30am - 10:00am 👀’s on possible 6 month extension news which can come any day now
0 · Reply
Carter123456
Carter123456 Feb. 23 at 1:04 PM
$OSRH news this week?
1 · Reply
KeepItRealistic
KeepItRealistic Feb. 22 at 6:57 PM
$OSRH When combined with RMC's established, cash-flow-generating operating platform, we believe Woori IO's differentiated technology and expanded commercial optionality create a compelling foundation for growth. Upon consummation of such merger, the combined entity will be evaluated with a view toward a Korean listing, with consideration given to the growth-oriented KOSDAQ market which has recently reached its highest index level in approximately 25 years.
0 · Reply
JeffersonSovereign
JeffersonSovereign Feb. 22 at 6:20 PM
$OSRH 500$ Osrh 5x = 2500$ Gcts 10x = 25 000$ Something else 3-5x = 100 000$ That easy with luck heh
1 · Reply
Bearbull_Baggins
Bearbull_Baggins Feb. 22 at 12:43 AM
$OSRH So this is super interesting. I found this on Fintel. Someone back in November laid out a crazy detailed analysis of OSRHs price action and the obvious manipulation we see from low volume slow drawn out downward pressure to random lightning quick spikes, and requested it be analyzed by Fintel AI. Here is the answer. This is all still very relevant and should make you feel confident a major re-pricing is literally inevitable.
1 · Reply
Bearbull_Baggins
Bearbull_Baggins Feb. 21 at 11:22 PM
$OSRH New 13Fs were updated last week. While it is difficult for a stock like this to even be eligible for most institutions to invest in yet, we are indeed getting buys. And these guys obviously aren't worried about price: Advisor Group Holdings (NEW) Point72 Asset Management (NEW) Jane Street Group (NEW) Mint Tower Capital Management (HELD) Vanguard Group (HELD) Geode Capital Management (INCREASE +3.09%) UBS Group AG (RE-INVESTED) Once this is officially "de-risked", this stock is going to violently surge due to both retail day traders and new institutional interest competing for shares in this tiny float.
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 21 at 4:41 PM
$OSRH the six month bid compliance extension news will likely be announced this coming week Many will be chasing after this news removes all fears and sets up for the other major catalysts listed below which will then move us towards our $10 🎯 👇 - Woori IO distribution news - $815M Term sheet update on Vaximm - RMC & Woori IO merger + IPO https://www.newsfilecorp.com/release/276983/Emerging-Growth-Research-Issues-Flash-Report-on-OSR-Holdings-Inc.-Reaffirms-BuyEmerging-Rating-and-10.00-Price-Target-Following-Major-Licensing-Agreement
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 21 at 12:09 AM
$OSRH ZERO effect painting a close 👇
0 · Reply
Hritzko
Hritzko Feb. 20 at 11:07 PM
$OSRH Added another 5k near close . OSRH News imminent imho on any front including business operations.
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 10:32 PM
$OSRH No proxy = extension news incoming https://www.otcmarkets.com/stock/OSRH/disclosure
0 · Reply
Roland115
Roland115 Feb. 20 at 10:15 PM
$OSRH below 0.40 they i buy another batch ✅
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 10:13 PM
$OSRH one day closer to the inevitable HUGE 6 month bid compliance extension granted news. What other catalysts can we expect after the extension news to name a few 👇 - Woori IO distribution news - $815M Term sheet update on Vaximm - RMC & Woori IO merger + IPO See you above $1 shortly for starters Good riddance to the 🧠 ☠️ sellers today 😝
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 20 at 10:11 PM
$OSRH RSI: 28.93, MACD: -0.0604 Vol: 0.11, MA20: 0.55, MA50: 0.61 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
1 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 9:19 PM
$OSRH another painting close at 4pm Likely a large short here It will squeeze next week on extension news
1 · Reply
Spiderman1979
Spiderman1979 Feb. 20 at 9:00 PM
$OSRH Professional Background: Before his current role at OSR Holdings, Mr. Hwang founded and has been Managing Partner of Bellevue Capital Management (BCM) since August 2012, where he led growth and expansion of the healthcare investment group across the U.S., South Korea, and Switzerland. � SEC He also serves as CEO of BCME (a related entity) and has been Chairman of the Board of Vaximm AG since November 2022. �
1 · Reply
Spiderman1979
Spiderman1979 Feb. 20 at 8:53 PM
$OSRH we need to hold 40 cents! Common!
1 · Reply
JJBurch
JJBurch Feb. 20 at 8:53 PM
$OSRH has been trading like a RS is coming If that’s coming I hope they announce it this weekend and get it out of the way Probably a small one What, a 10-1 split?
3 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 3:26 PM
$OSRH unbelievable amount of shareholder equity ($134M) in this company 👇 Usually these small caps struggle to have the minimum $2.5 million ! Our Market Cap at 11m is ridiculously low ! See you over $1+++
0 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 3:12 PM
$OSRH VWAP .445 Shares at this level are getting harder to acquire as we approach the expected extension news
0 · Reply
Carter123456
Carter123456 Feb. 20 at 2:28 PM
$OSRH something has to be brewing they don’t go without news this often
1 · Reply
KeepItRealistic
KeepItRealistic Feb. 20 at 1:59 PM
$OSRH the potential with this company is just phenomenal The reason why they got a $10 🎯 👇
1 · Reply